Recombinant Rat GM-CSF

Recombinant Rat GMCSF is widely used in research because it is a potent cytokine that regulates the growth, differentiation, and activation of multiple hematopoietic and immune cell types, making it essential for studies involving rat immune function, inflammation, hematopoiesis, and disease models.

Key scientific reasons to use recombinant rat GMCSF in research applications include:

• Stimulation of Hematopoietic Progenitors: GMCSF promotes the proliferation and differentiation of bone marrow progenitor cells into granulocytes, monocytes/macrophages, and other myeloid lineages, which is critical for in vitro and in vivo studies of hematopoiesis and immune cell development.
• Immune Cell Activation and Modulation: It acts as a survival and activation factor for mature granulocytes, monocytes/macrophages, and eosinophils, enhancing their effector functions such as phagocytosis, cytokine secretion, and antigen presentation.
• Modeling Inflammatory and Infectious Diseases: GMCSF is central to the regulation of inflammatory responses, making it valuable for modeling autoimmune diseases, allergic inflammation, and infection in rats. It has been shown to enhance host defense mechanisms and improve outcomes in infection models, such as fungal and bacterial challenges.
• Therapeutic and Translational Research: Recombinant GMCSF is used to study potential therapies for conditions involving GMCSF deficiency or dysfunction, including immune deficiencies, chemotherapyinduced neutropenia, and as an adjuvant in cancer immunotherapy research.
• Neuroimmunology and Tissue Repair: GMCSF has roles in the central nervous system, influencing food intake, body weight, and neuroinflammation, and is involved in tissue repair and regeneration studies.
• SpeciesSpecific Activity: Using recombinant rat GMCSF ensures optimal activity and receptor compatibility in rat models, which is crucial for accurate and reproducible results in preclinical studies.

Typical applications include:

• In vitro differentiation and activation of rat bone marrowderived macrophages or dendritic cells.
• In vivo modulation of immune responses in rat models of infection, inflammation, autoimmunity, or cancer.
• Functional assays to study phagocytosis, cytokine production, and immune cell signaling pathways.

In summary, recombinant rat GMCSF is a versatile tool for dissecting immune mechanisms, modeling diseases, and evaluating therapeutic strategies in rat systems, due to its broad and potent effects on myeloid and immune cell biology.

Yes, recombinant rat GMCSF can be used as a standard for quantification or calibration in ELISA assays, provided it is properly validated and matched to your assay system.

Supporting details:

• Recombinant rat GMCSF is widely used as an ELISA standard: Multiple technical datasheets and protocols explicitly state that recombinant rat GMCSF is suitable as a quantitative standard for sandwich ELISA assays measuring rat GMCSF protein levels. This is standard practice in commercial ELISA kits and custom assay development.

• Assay validation and parallelism: Validation studies show that doseresponse curves generated with recombinant rat GMCSF standards are parallel to those obtained with natural rat GMCSF, indicating that the recombinant protein is immunologically equivalent for quantification purposes in these assays. This parallelism is critical for accurate quantification of endogenous samples.

• Formulation considerations: Recombinant GMCSF is often supplied lyophilized and may include carrier proteins such as BSA for stability. For ELISA calibration, it is generally recommended to use the formulation with BSA unless your assay is sensitive to carrier proteins. Always reconstitute and dilute the standard according to the assay protocol to ensure consistency.

• Assay specificity: Commercial ELISA kits for rat GMCSF are designed to detect both natural and recombinant forms of the protein, and their antibodies are validated for this purpose.

• Best practices:

  • Use the same buffer and diluent recommended by your ELISA protocol for reconstituting and diluting the recombinant standard.
  • Generate a fresh standard curve for each assay run.
  • Confirm that the recombinant standard matches the sequence and posttranslational modifications (e.g., glycosylation) relevant to your assay, especially if you are comparing to native samples.

Limitations:

• If your recombinant GMCSF differs significantly in structure (e.g., glycosylation state) from the native protein in your samples, minor quantification discrepancies may occur. However, for most research applications, these differences are negligible when using validated commercial reagents.
• Always ensure the recombinant standard is of high purity and endotoxinfree for reliable results.

Summary:
Recombinant rat GMCSF is a standard, validated choice for ELISA calibration and quantification, provided you follow assayspecific protocols and validation steps.

Recombinant Rat GMCSF has been validated for a range of applications in published research, primarily involving functional and bioactivity assays, immunological studies, and in vivo experimentation.

Key validated applications include:

• Functional/Bioassay: Used to stimulate proliferation and differentiation of hematopoietic progenitors, and to assess activation and survival of granulocytes, monocytes/macrophages, and eosinophils in vitro. This includes colony formation assays for granulocytemacrophage progenitors and functional studies on immune cell activation.
• ELISA (EnzymeLinked Immunosorbent Assay): Employed as a quantitative standard for measuring rat GMCSF protein levels in biological samples.
• Western Blot: Used as a positive control or standard for detecting GMCSF protein in cell lysates or tissue extracts.
• Immunohistochemistry: Applied to detect GMCSF or GMCSFresponsive cells in tissue sections.
• Blocking Assay: Utilized to block GMCSF activity in functional studies to elucidate its biological role.
• Immunoprecipitation: Used to isolate GMCSF or GMCSFinteracting proteins from complex mixtures.

In vivo applications in published research include:

• Animal models of disease: Recombinant rat GMCSF has been administered to rats to study its effects on immune modulation, neuroprotection, and inflammation. For example:
  • Modulation of microglial activation and neuroprotection in models of neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease.
  • Regulation of food intake and body weight via central nervous system administration.
  • Investigation of optic nerve inflammation and demyelination in models of ischemic optic neuropathy.
  • Induction of M2like macrophages for tissue repair in vivo.
• Cellular assays: Used to stimulate rat immune cells (e.g., macrophages, dendritic cells, microglia) in vitro to study cytokine secretion, phagocytosis, and cell signaling pathways.

Summary Table of Validated Applications

Additional Notes:

• Recombinant rat GMCSF is widely used to study hematopoiesis, immune cell function, and disease mechanisms in rat models.
• It is also used as a tool to generate or manipulate specific immune cell populations (e.g., dendritic cells, macrophages) for downstream applications.
• Published studies have validated its use in both in vitro and in vivo settings, supporting its reliability for translational and mechanistic research.

If you require details on a specific application or protocol, please specify the context or experimental system of interest.

To reconstitute and prepare Recombinant Rat GMCSF protein for cell culture experiments, first briefly centrifuge the vial to collect the lyophilized powder at the bottom. Reconstitute the protein at a concentration of 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin (BSA) as a carrier protein to stabilize the cytokine and prevent adsorption to plastic surfaces.

Stepbystep protocol:

• Centrifuge the vial before opening to ensure all lyophilized material is at the bottom.
• Add sterile PBS (phosphatebuffered saline) containing at least 0.1% BSA to achieve a final concentration of 50 μg/mL.
• Gently pipette the solution up and down or swirl to fully dissolve the protein; avoid vigorous vortexing to prevent denaturation.
• Aliquot the reconstituted protein into small volumes to avoid repeated freezethaw cycles, which can degrade the protein.
• Store aliquots at –20°C or colder for longterm storage; avoid repeated freezethaw cycles.

Additional notes:

• If a different working concentration is required for your assay, further dilute the stock solution in cell culture medium or PBS with 0.1% BSA immediately before use.
• For cell culture applications, ensure all solutions are sterile and endotoxinfree.
• The presence of a carrier protein (BSA or HSA) is critical for stability, especially at low concentrations.
• The reconstituted protein is typically stable for at least one week at 4°C and for several months at –20°C or below when aliquoted with carrier protein.

Summary Table:

This protocol ensures optimal stability and biological activity of recombinant rat GMCSF for cell culture experiments.